A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

Please provide your email address to receive an email when new articles are posted on . “We found an association between hormone therapy use and greater weight loss in postmenopausal women,” Regina ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

Hormones like insulin, cortisol, thyroid hormones, and testosterone play a direct role in metabolism, appetite, and fat storage. Hormone imbalances can make weight loss harder and contribute to weight ...

ORLANDO -- Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits of frustrating body issues, like excess weight that won’t come off despite ...

NEW ORLEANS — Many of us who have tried to lose weight have been told we're just not trying hard enough. And for women after menopause, the newest study suggests it may be something completely out of ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, ...

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

Merging clinical oversight with aesthetic and wellness solutions, AZ Med Spa 48 in Peoria now highlights medically supervised ...